CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析

◆英語タイトル:CorMedix Inc (CRMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137874FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solution to decrease the threat of infection and blood clots in central venous catheters (CVCs). CorMedix also develops therapeutic products for the prevention and treatment of inflammatory diseases. CorMedix is headquartered in Berkeley Heights, New Jersey, the US.

CorMedix Inc Key Recent Developments

Apr 07,2021: CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 30,2021: CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Mar 23,2021: CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30
Mar 15,2021: CorMedix approved to sell $1.3 million of NOL tax benefits through the New Jersey Economic Development Authority Program
Mar 08,2021: CorMedix to Host Regulatory Update Conference Call

This comprehensive SWOT profile of CorMedix Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CorMedix Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CorMedix Inc – Key Information
CorMedix Inc – Overview
CorMedix Inc – Key Employees
CorMedix Inc – Key Employee Biographies
CorMedix Inc – Key Operational Heads
CorMedix Inc – Major Products and Services
CorMedix Inc – History
CorMedix Inc – Company Statement
CorMedix Inc – Locations And Subsidiaries
CorMedix Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CorMedix Inc – Business Description
CorMedix Inc – Corporate Strategy
CorMedix Inc – SWOT Analysis
SWOT Analysis – Overview
CorMedix Inc – Strengths
CorMedix Inc – Weaknesses
CorMedix Inc – Opportunities
CorMedix Inc – Threats
CorMedix Inc – Key Competitors

Section 3 – Company Financial Performance Charts

CorMedix Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CorMedix Inc, Key Information
CorMedix Inc, Key Ratios
CorMedix Inc, Share Data
CorMedix Inc, Major Products and Services
CorMedix Inc, History
CorMedix Inc, Key Employees
CorMedix Inc, Key Employee Biographies
CorMedix Inc, Key Operational Heads
CorMedix Inc, Other Locations
CorMedix Inc, Subsidiaries
CorMedix Inc, Key Competitors
CorMedix Inc, SWOT Analysis
CorMedix Inc, Ratios based on current share price
CorMedix Inc, Annual Ratios
CorMedix Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eris Lifesciences Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a pharmaceutical company that manufactures and commercializes generics products. The company through its divisions provides wide range of products including Maxum, Decal, Eritel H, Eritel CH 80 LS, Glimisave Max Forte 1, Mac Rabonik Plus, Vomisave …
  • ARMO Biosciences Inc (ARMO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARMO Biosciences Inc (ARMO Biosciences) is an immuno-oncology company that develops tumors treatment drugs. Its pipeline drug candidates include AM0010, AM0015, AM0012, AM0003 and AM0001. ARMO Biosciences’s lead immunotherapy AM0010 is along-acting form of recombinant human Interleukin 10 (I …
  • SI2 Technologies, Inc.:企業の戦略・SWOT・財務情報
    SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PG&E Corporation:企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Florida Keys Electric Cooperative Association Inc:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Red Electrica Corporacion, SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion, SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red E …
  • Centerchem Inc:企業の戦略・SWOT・財務情報
    Centerchem Inc - Strategy, SWOT and Corporate Finance Report Summary Centerchem Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Air France Industries KLM Engineering and Maintenance:企業の戦略・SWOT・財務情報
    Air France Industries KLM Engineering and Maintenance - Strategy, SWOT and Corporate Finance Report Summary Air France Industries KLM Engineering and Maintenance - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Solidarity Bahrain B.S.C.:企業の戦略・SWOT・財務情報
    Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report Summary Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Accugenomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Westdeutsche Immobilien Servicing AG:企業の戦略・SWOT・財務分析
    Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report Summary Westdeutsche Immobilien Servicing AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Liechtensteinische Landesbank AG:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Blokker Holdings N.V.:企業の戦略的SWOT分析
    Blokker Holdings N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Pt Mandom Indonesia Tbk:企業の戦略・SWOT・財務情報
    Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PulteGroup, Inc.:企業の戦略・SWOT・財務情報
    PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary PulteGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Lincoln Pharmaceuticals Ltd (LINCOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lincoln Pharmaceuticals Ltd (Lincoln Pharmaceuticals) manufactures, markets and exports pharmaceutical products. The company provides pharmaceuticals for cardiovascular, central nervous system, dermatology and ear nose throat disorders; gastrointestinal and genitourinary infections; hematolo …
  • Bellvitge Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center that offers health care development solutions. The center conducts clinical and basic research for developing treatments and techniques to improve health care. It offers its research work in the fields of neuro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆